Immunogenicity 12442
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CHST14
Transcript ID
uc001zlw.3
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (376 aa)
MFPRP
1
LTPLA
6
APNGA
11
EPLGR
16
ALRRA
21
PLGRA
26
RAGLG
31
GPPLL
36
LPSML
41
MFAVI
46
VASSG
51
LLLMI
56
ERGIL
61
AEMKP
66
LPLHP
71
PGREG
76
TAWRG
81
KAPKP
86
GGLSL
91
RAGDA
96
DLQVR
101
QDVRN
106
RTLRA
111
VCGQP
116
GMPRD
121
PWDLP
126
VGQRR
131
TLLRH
136
ILVSD
141
RYRFL
146
YCYVP
151
KVACS
156
NWKRV
161
MKVLA
166
GVLDS
171
VDVRL
176
KMDHR
181
SDLVF
186
LADLR
191
PEEIR
196
YRLQH
201
YFKFL
206
FVREP
211
LERLL
216
SAYRN
221
KFGEI
226
REYQQ
231
RYGAE
236
IVRRY
241
RAGAG
246
PSPAG
251
DDVTF
256
PEFLR
261
YLVDE
266
DPERM
271
NEHWM
276
PVYHL
281
CQPCA
286
VHYDF
291
VGSYE
296
RLEAD
301
ANQVL
306
EWVRA
311
PPHVR
316
FPARQ
321
AWYRP
326
ASPES
331
LHYHL
336
CSAPR
341
ALLQD
346
VLPKY
351
ILDFS
356
LFAYP
361
LPNVT
366
KEACQ
371
Q
376
Mutation Information
DNA mutation:
None
Peptide Range:
258 ~ 282
Mut AA position:
270 (13 in Wild Type peptide)
Alignment
Wild Type:
"VTFPEFLRYLVDEDPERMNEHWMPV
||||||||||||.||||||||||||
Mutant:
VTFPEFLRYLVDVDPERMNEHWMPV"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CHST14
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay